8 (0) | ☆ 4331 . Mabion sa is a biotechnology company. No employees (address), not declared. The company is focused on the development of humanized monoclonal antibodies (mabs) technology. Registry of commerce/krs, krs 0000340462.
The company is focused on the development of humanized monoclonal antibodies (mabs) technology.
No employees (address), not declared. Registry of commerce/krs, krs 0000340462. Mabion sa is a polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. Mabion sa is a biotechnology company. The company is focused on the development of humanized monoclonal antibodies (mabs) technology. 8 (0) | ☆ 4331 . 8 paź, 17:04 84.3 +9.4 (+12.55%).
Registry of commerce/krs, krs 0000340462. No employees (address), not declared. 8 (0) | ☆ 4331 . 8 paź, 17:04 84.3 +9.4 (+12.55%). Mabion sa is a polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology.
Mabion sa is a biotechnology company.
No employees (address), not declared. Mabion sa is a biotechnology company. 8 (0) | ☆ 4331 . 8 paź, 17:04 84.3 +9.4 (+12.55%). The company is focused on the development of humanized monoclonal antibodies (mabs) technology. Registry of commerce/krs, krs 0000340462. Mabion sa is a polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology.
No employees (address), not declared. 8 paź, 17:04 84.3 +9.4 (+12.55%). Mabion sa is a biotechnology company. Mabion sa is a polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. The company is focused on the development of humanized monoclonal antibodies (mabs) technology.
No employees (address), not declared.
8 paź, 17:04 84.3 +9.4 (+12.55%). No employees (address), not declared. Mabion sa is a biotechnology company. The company is focused on the development of humanized monoclonal antibodies (mabs) technology. 8 (0) | ☆ 4331 . Registry of commerce/krs, krs 0000340462. Mabion sa is a polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology.
Mabion Sa / Mabion Akcje / Mabion dostaÅ‚ rykoszetem przez fuzjÄ™ / Registry of commerce/krs, krs 0000340462.. Mabion sa is a biotechnology company. Mabion sa is a polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. 8 paź, 17:04 84.3 +9.4 (+12.55%). Registry of commerce/krs, krs 0000340462. The company is focused on the development of humanized monoclonal antibodies (mabs) technology.
8 paź, 17:04 843 +94 (+1255%) mabion. No employees (address), not declared.
